Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)

Yahoo Finance15:17

Can the "miracle drug" of 100% preventing AIDS break the deadlock, but the stock price of Gilead (GILD.US) cannot be happy?

Can the 100% HIV prevention "miracle drug" become Gilead's next ace?

Zhitong Finance09:55

Gilead Sciences(GILD.US) Officer Sells US$137.26K in Common Stock

$Gilead Sciences(GILD.US)$ Officer Parsey Merdad sold 2,000 shares of common stock on Jul 1, 2024 at an average price of $68.63 for a total value of $137.26K.Source: Announcement What is statement of

Futu News08:47

Form 144 | Gilead Sciences(GILD.US) Officer Proposes to Sell 137.26K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Gilead Sciences(GILD.US)$ Officer MERDAD V PARSEY intends to sell 2,000 shares of its common stock on Jul 1, with a total market value of approximately $137.26K. Sou

Futu News05:16

HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study

HOOKIPA Pharma (HOOK) said Monday the first person has been dosed in its phase 1b study of its investigational vaccine HB-500 for the treatment of HIV. The study will evaluate safety and tolerability,

MT Newswires05:15

RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $74 Price Target

RBC Capital analyst Brian Abrahams reiterates Gilead Sciences (NASDAQ:GILD) with a Sector Perform and maintains $74 price target.

BenzingaJul 1 22:00